Search

Your search keyword '"Kourea, Helen"' showing total 144 results

Search Constraints

Start Over You searched for: Author "Kourea, Helen" Remove constraint Author: "Kourea, Helen"
144 results on '"Kourea, Helen"'

Search Results

1. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes

2. Nationwide Real-World Data of Microsatellite Instability and/or Mismatch Repair Deficiency in Cancer: Prevalence and Testing Patterns

3. Altered Expression of Intestinal Tight Junction Proteins in Heart Failure Patients with Reduced or Preserved Ejection Fraction: A Pathogenetic Mechanism of Intestinal Hyperpermeability

4. Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes

5. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

6. Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based Regimens

7. The expression of vascular endothelial growth factor-C correlates with lymphatic microvessel density and lymph node metastasis in prostate carcinoma: An immunohistochemical study

11. Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer

14. Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-based Regimens

15. Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer

17. Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group

21. Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab

22. The histone Lysine Methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming

26. Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer

27. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming

32. Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study

33. Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study

34. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.

35. Abstract 4528: Chromatin regulation by ING3 leads to tumor suppressive effects in pancreatic cancer through distinct signaling pathways

37. Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials

38. Congenital Midline Cervical Cleft: Diagnosis, Pathologic Findings, and Early Stage Treatment

41. Differential Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer Subtypes

48. Deletions of the INK4AGene Occur in Malignant Peripheral Nerve Sheath Tumors but not in Neurofibromas

49. Expression of p27kipand Other Cell Cycle Regulators in Malignant Peripheral Nerve Sheath Tumors and Neurofibromas

50. Subdiaphragmatic and intrathoracic paraspinal malignant peripheral nerve sheath tumors<FNR HREF="fn1"></FNR><FN ID="fn1"> Presented in part at the annual meeting of the U.S. and Canadian Academy of Pathology, Washington, DC, March 1996. </FN>

Catalog

Books, media, physical & digital resources